ADMA Biologics, Inc. (ADMA)
17.31
-0.19
(-1.09%)
USD |
NASDAQ |
Jan 16, 16:00
17.40
+0.09
(+0.52%)
After-Hours: 20:00
ADMA Biologics Total Liabilities (Quarterly): 137.50M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 212.90M |
| Vanda Pharmaceuticals, Inc. | 135.14M |
| Aldeyra Therapeutics, Inc. | 28.56M |
| Marker Therapeutics, Inc. | 3.346M |
| CorMedix, Inc. | 376.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 568.69M |
| Shareholders Equity (Quarterly) | 431.19M |
| Debt to Equity Ratio | 0.1928 |
| Current Ratio | 7.128 |
| Net Debt Paydown Yield | 0.33% |